BRCA1 transcriptionally regulates genes involved in breast tumorigenesis
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
Loss of function of BRCA1 caused by inherited mutation and tissue-specific somatic mutation leads to breast and ovarian cancer. Nearly all BRCA1 germ-line mutations involve truncation or loss of the C-terminal BRCT transcriptional activation domain, suggesting that transcriptional regulation is a critical function of the wild-type gene. The purpose of this project was to determine whether there is a link between the role of BRCA1 in transcriptional regulation and its role in tumor suppression. We developed a cell line (in which BRCA1 can be induced) and used microarray analysis to compare transcription profiles of epithelial cells with low endogenous levels of BRCA1 vs. transcription profiles of cells with 2–4-fold higher induced levels of expression of BRCA1. At these levels of expression, BRCA1 did not induce apoptosis. Undirected cluster analysis of six paired experiments revealed 373 genes, the expression of which was altered significantly and consistently by BRCA1 induction. Expression of 62 genes was altered more than 2-fold. BRCA1-regulated genes associated with breast tumorigenesis included the estrogen-responsive genes MYC and cyclin D1, which are overexpressed in many breast tumors; STAT1 and JAK1 , key components of the cytokine signal transduction pathway; the extracellular matrix protein laminin 3A; ID4 , an inhibitor of DNA-binding transcriptional activators, which in turn negatively regulates BRCA1 expression; and the prohormone stanniocalcin, expression of which is lost in breast tumor cells. Coordinated expression of BRCA1 with ID4 and with stanniocalcin was confirmed in primary breast and ovarian tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
BRCA1 required for transcription-coupled repair of oxidative DNA damage
Gowen, L. C., Avrutskaya, A. V., Latour, A. M., Koller, B. H., & Leadon, S. A. (1998) · Science · doi:10.1126/science.281.5379.1009 · Cited by 496
RetractedMolecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,071
Elkablawy, M. A., Albasri, A. M., Mohammed, R. A., Hussainy, A. S., Nouh, M. M., & Alhujaily, A. S. (2016) · Saudi Medical Journal · doi:10.15537/smj.2016.2.12285 · Cited by 4,382
Expression monitoring by hybridization to high-density oligonucleotide arrays
Lockhart, D. J., Dong, H., Byrne, M. C., Follettie, M. T., Gallo, M. V., Chee, M. S., Mittmann, M., Wang, C., Kobayashi, M., Norton, H., et al. (1996) · Nature Biotechnology · doi:10.1038/nbt1296-1675 · Cited by 2,840
Light-Directed, Spatially Addressable Parallel Chemical Synthesis
Fodor, S. P. A., Read, J. L., Pirrung, M. C., Stryer, L., Lu, A. T., & Solas, D. (1991) · Science · doi:10.1126/science.1990438 · Cited by 2,696
Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21
Hall, J. M., Lee, M. K., Newman, B., Morrow, J. E., Anderson, L. A., Huey, B., & King, M.-C. (1990) · Science · doi:10.1126/science.2270482 · Cited by 2,550
Self-citation
Cited by
Triple negative tumours: a critical review
Reis‐Filho, J. S., & Tutt, A. N. J. (2008) · Histopathology · doi:10.1111/j.1365-2559.2007.02889.x · Cited by 884
Badve, S., Dabbs, D. J., Schnitt, S. J., Baehner, F. L., Decker, T., Eusebi, V., Fox, S. B., Ichihara, S., Jacquemier, J., Lakhani, S. R., et al. (2011) · Modern Pathology · doi:10.1038/modpathol.2010.200 · Cited by 680
Drǎghici, S., Khatri, P., Martins, R. P., Ostermeier, G. C., & Krawetz, S. A. (2003) · Genomics · doi:10.1016/s0888-7543(02)00021-6 · Cited by 578
Id family of helix-loop-helix proteins in cancer
Perk, J., Iavarone, A., & Benezra, R. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1673 · Cited by 535
Liu, X., Holstege, H., van der Gulden, H., Treur-Mulder, M., Zevenhoven, J., Velds, A., Kerkhoven, R. M., van Vliet, M. H., Wessels, L. F. A., Peterse, J. L., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702969104 · Cited by 474
Oncogenic Pathway Combinations Predict Clinical Prognosis in Gastric Cancer
Ooi, C. H., Ivanova, T., Wu, J., Lee, M., Tan, I. B., Tao, J., Ward, L., Koo, J. H., Gopalakrishnan, V., Zhu, Y., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000676 · Cited by 447
Self-citationThe ID proteins: master regulators of cancer stem cells and tumour aggressiveness
Lasorella, A., Benezra, R., & Iavarone, A. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3638 · Cited by 355
The role of BRCA1 in transcriptional regulation and cell cycle control
Mullan, P. B., Quinn, J. E., & Harkin, D. P. (2006) · Oncogene · doi:10.1038/sj.onc.1209872 · Cited by 319
Centrosome amplification, chromosome instability and cancer development
Fukasawa, K. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.12.028 · Cited by 318
BRCA Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance
Gorodetska, I., Kozeretska, I., & Dubrovska, A. (2019) · Journal of Cancer · doi:10.7150/jca.30410 · Cited by 269
Coser, K. R., Chesnes, J., Hur, J., Ray, S., Isselbacher, K. J., & Shioda, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235866100 · Cited by 241
BRCA1 Induces Antioxidant Gene Expression and Resistance to Oxidative Stress
Bae, I., Fan, S., Meng, Q., Rih, J. K., Kim, H. J., Kang, H. J., Xu, J., Goldberg, I. D., Jaiswal, A. K., & Rosen, E. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1119 · Cited by 222
“gene regulation by BRCA1 in 293T cells (26), colon cancer cells (27), and Brca1-deficient mouse embryonic stem cells (28).”
The role of PAPP-A in the IGF system: location, location, location
Oxvig, C. (2015) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-015-0259-9 · Cited by 198
“For example, 1) loss of BRCA1 tumor suppressor function in breast cancer causes STC1 expression to become undetectable (Welcsh et al. 2002), 2) STC1 is down-regulated in cervical cancer tissue, and STC1 knockdown in a cervical cancer derived cells causes increased cell growth and invasiveness, while STC1 overexpressio…”
BackgroundThe execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesis
Fontemaggi, G., Dell'Orso, S., Trisciuoglio, D., Shay, T., Melucci, E., Fazi, F., Terrenato, I., Mottolese, M., Muti, P., Domany, E., et al. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1669 · Cited by 195
McMullin, R. P., Wittner, B. S., Yang, C., Denton-Schneider, B. R., Hicks, D., Singavarapu, R., Moulis, S., Lee, J., Akbari, M. R., Narod, S. A., et al. (2014) · Breast Cancer Research · doi:10.1186/bcr3625 · Cited by 169
“The top gene set identified was BRCA1_OVEREXP_DN, which is comprised of probe sets that were downregulated by two- to fourfold after inducible expression of BRCA1 in the BRCA1low, ER + EcR-293 human embryonal kidney epithelial cell line [23].”
BackgroundJepsen, M. R., Kløverpris, S., Mikkelsen, J. H., Pedersen, J. H., Füchtbauer, E.-M., Laursen, L. S., & Oxvig, C. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.611665 · Cited by 166
“For example, loss of BRCA1 tumor suppressor function in breast cancer causes STC1 expression to become undetectable (54), and late relapse of breast cancer correlates with high expression of STC1 and STC2 (55).”
BackgroundHartmann, L. C., Lu, K. H., Linette, G. P., Cliby, W. A., Kalli, K. R., Gershenson, D., Bast, R. C., Stec, J., Iartchouk, N., Smith, D. I., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1673 · Cited by 141
“subjects 51 28 Median age at diagnosis 62 (39-81) 62 (39-76) Median TTR (mo)* 21 14 No.”
BackgroundInfluentialBACH1 is a DNA repair protein supporting BRCA1 damage response
Peng, M., Litman, R., Jin, Z., Fong, G., & Cantor, S. B. (2006) · Oncogene · doi:10.1038/sj.onc.1209257 · Cited by 88
“…functions including ubiquitin ligase activity, (Wu et al., 1996; Baer and Ludwig, 2002) transcriptional activity, (MacLachlan et al., 2002; Monteiro, 2002; Venkitaraman, 2002; Welcsh et al., 2002) DNA repair, cell cycle control, and chromatin remodeling functions (Scully and Livingston, 2000).”
BackgroundShaashua, L., Ben-Shmuel, A., Pevsner-Fischer, M., Friedman, G., Levi-Galibov, O., Nandakumar, S., Barki, D., Nevo, R., Brown, L. E., Zhang, W., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34081-3 · Cited by 79
Metadata
- Authors
- Welcsh, P. L., Lee, M. K., Gonzalez-Hernandez, R. M., Black, D. J., Mahadevappa, M., Swisher, E. M., Warrington, J. A., & King, M.-C.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2002-05-21
- Volume
- 99
- Issue
- 11
- Pages
- 7560-7565
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2052244380
- Cited by
- 256
- References
- 59
- FWCI
- 12.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.